Learn more about Lindus Health from our blog page. Our posts cover an array of topics from clinical developments to diversity.
The global in vitro diagnostics (IVD) market is evolving rapidly, driven by growing demand for faster, more accessible testing across clinical and consumer settings. As healthcare systems shift toward earlier detection, personalised treatment, and decentralised care, the need for innovative diagnostics has never been greater.
Psychedelics are reshaping mental health treatment, with over 100 active psilocybin trials reflecting renewed interest after decades of stalled progress due to stigma and regulation.
The transition from IVDD to IVDR represents the most significant regulatory change for diagnostic devices in Europe in decades. With extended transition periods now in place, clinical study sponsors face both new challenges and opportunities. Understanding the evolving requirements is essential to staying compliant and keeping studies on track.
The continuous glucose monitor (CGM) has evolved far beyond its original purpose as a diabetes management tool. Recently, the FDA cleared the first over-the-counter CGM intended for anyone 18 years and older who does not use insulin, including those without diabetes who want to better understand how diet and exercise impact blood sugar levels. This landmark approval has opened new frontiers in personalized medicine, where metabolic insights drive precision health interventions.
he relentless pursuit of medical advancement has led to a surge in the demand for high-quality clinical research. With an ever-growing number of pharmaceutical and biotech companies outsourcing their research and development (R&D) processes, the role of Clinical Research Organizations (CROs) has become indispensable. This article sheds light on the top CROs in the US, highlighting their strengths, core service offerings, and unique features that make them a preferred choice for sponsors.
The global contract research organization (CRO) market is a rapidly evolving industry. It has become increasingly crucial for pharmaceutical, biotech, and medtech industries that rely on these organizations to test, refine, and market their latest drugs and devices. The CRO market is projected to grow at a compound annual growth rate (CAGR) of around 10.7% from 2023 to 2028, reaching an estimated worth of USD 127.3 billion by 2028. This article provides an insightful overview of the top 5 CROs that are currently leading the industry.
Stay informed about the latest breakthroughs in endometriosis clinical trials with our comprehensive overview.
Explore the latest breakthroughs in Type 1 diabetes clinical trials and the promising outlook for improved treatment options.
Discover the latest advancements in COPD clinical trials and the promising opportunities they offer for patients.
Discover the cutting-edge developments in schizophrenia research with our in-depth exploration of the latest clinical trials.
Explore the latest advancements in asthma treatment and research through clinical trials.
Discover the latest advancements in dementia clinical trials with our comprehensive guide.
Discover the cutting-edge developments in pulmonary fibrosis clinical trials with our comprehensive article.
Discover the latest breakthroughs in migraine treatment as clinical trials unveil promising results.
Discover the most recent advancements in Alzheimer's disease clinical trials and learn about the cutting-edge research and treatments that offer hope for patients and their families.
Discover the latest advancements in the treatment and research of sleep apnea through clinical trials.
Explore the latest advancements in epilepsy clinical trials and discover the promising path to effective treatment options.
Discover the most recent advancements in Type 2 Diabetes clinical trials, from groundbreaking treatments to promising research findings.
Explore the latest developments in Huntington's disease clinical trials and discover the promising outlook for patients.
Discover the latest clinical trials for idiopathic pulmonary fibrosis and explore the promising advances in research.
Explore the latest advancements in diabetic neuropathy clinical trials with our comprehensive review.
Discover the cutting-edge advancements in obsessive-compulsive disorder (OCD) treatment with this comprehensive overview of the latest clinical trials.
Explore the latest breakthroughs in ovarian cancer clinical trials and gain a comprehensive understanding of the advancements shaping the future of treatment.
Discover everything you need to know about frontotemporal dementia clinical trials in this comprehensive guide.
Explore the latest advancements in uterine fibroids clinical trials in this comprehensive overview.
Explore the cutting-edge advancements in stroke clinical trials with our comprehensive overview.